Search
Patexia Research
Case number IPR2018-00086

Pfizer, Inc. v. Biogen, Inc. et al. > Documents

Date Field Doc. No.PartyDescription
Jul 20, 2018 13 Notice of Refund Download
Jul 2, 2018 12 Motion For Refund Of Post-Institution Fee Download
May 31, 2018 11 Denying Institution of Inter Partes Review 35 U.S.C. sec 314(a) and 37 C.F.R. sec 42.108(c) Download
Mar 7, 2018 2006 Ex 2006 '612 IPR Petition Download
Mar 7, 2018 2009 Ex 2009 Merrill 2010 Download
Mar 7, 2018 10 Patent Owners' Preliminary Response Download
Mar 7, 2018 9 Patent Owners' Exhibit List Download
Mar 7, 2018 2007 Ex 2007 Kresina Download
Mar 7, 2018 2005 Ex 2005 US Patent No. 5,484,892 Download
Mar 7, 2018 2008 Ex 2008 Sternberg Download
Mar 7, 2018 2004 Ex 2004 Multani 1998 Download
Mar 7, 2018 2001 Ex 2001 US Patent No. 8,664,231 Download
Mar 7, 2018 2002 Ex 2002 Jones 1976 Download
Mar 7, 2018 2003 Ex 2003 Gans 1996 Download
Jan 31, 2018 8 Petitioner's Updated Mandatory Notice Download
Dec 27, 2017 7 Patent Owners' Updated Mandatory Notice Download
Dec 7, 2017 6 NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE Download
Nov 17, 2017 4 Power of Attorney-Genentech Download
Nov 17, 2017 5 Mandatory Notice Download
Nov 17, 2017 3 Power of Attorney-Biogen Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 5 Download
Nov 2, 2017 1004 Ex. 1004 - Belmont et al., "Pathology and Pathogenesis of Vascular Injury in Systemic Lupus Erythematosus," Arthritis & Rheumatism, 39(1):9-22 (1996) Download
Nov 2, 2017 1040 Ex. 1040 - Sean Henahan, "Anti-CD20 Antibodies Combining Well in Lymphoma Patients," Inpharma, 1136:9 (May 1998) Download
Nov 2, 2017 1037 Ex. 1037 - Remicade (infliximab) labeling (August 1998) ("Remicade" label") Download
Nov 2, 2017 1017 Ex. 1017 - Gary S. Hoffman and Ulrich Specks, "Antineutrophil Cytoplasmic Antibodies," Arthritis & Rheumatism, 41(9): 1521-1537 (1998) Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 3 Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 5 Download
Nov 2, 2017 1 PETITION FOR INTER PARTES REVIEW '843 Download
Nov 2, 2017 1023 Ex. 1023 - Theoharides et al., "7 Control of Pain and Inflammation," in Essential of Pharmacology 2d ed. (Theoharis C. Theoharides, ed.) 217-258 (1996) ("Massarotti I") Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 3 Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 3 Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 5 Download
Nov 2, 2017 2 Petitioner's Power of Attorney Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 5 Download
Nov 2, 2017 1039 Ex. 1039 - Charles Marwick, "Monoclonal Antibody to Treat Lymphoma," J. Am. Med. Ass'n, 278(8):616, 618 (August 27, 1997) Download
Nov 2, 2017 1038 Ex. 1038 - Gail A. Leget and Myron S. Czuczman "Use of Rituximab, the New FDA-Approved Antibody," Current Opinion in Oncology, 10:548-551 (1998) Download
Nov 2, 2017 1022 Ex. 1022 - Andrassy et al., "Wegener's Granulomatosis with Renal Involvement: Patient Survival and Correlations Between Initial Renal Function, Renal Histology, Therapy and Renal Outcome," Clinical Nephrology, 35(4):139-147 (1991) Download
Nov 2, 2017 1030 Ex. 1030 - U.S. Application No. 12/886,171, Notice of Allowability (dated May 24, 2013) Download
Nov 2, 2017 1005 Ex. 1005 - Danning et al., "Vasculitis Associated with Primary Rheumatologic Diseases," Current Opinion in Rheumatology, 10(1):58-65 (1998) Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 5 Download
Nov 2, 2017 1001 Ex. 1001 - U.S. Patent No. 8,545,843 B2 , Curd et al. Download
Nov 2, 2017 1018 Ex. 1018 - CGM Kallenberg and P Heeringa, "Pathogenesis of Vasculitis," Lupus, 7:280-284 (1998) Download
Nov 2, 2017 1033 Ex. 1033 - Darrell R. Anderson, U.S. Patent NO. 5,736,137 (issued April 7, 1998) Download
Nov 2, 2017 1029 Ex. 1029 - U.S. Application No. 12/886,171 Amendment to Accompany RCE (dated Nov. 20, 2012) Download
Nov 2, 2017 1032 Ex. 1032 - Maloney et al., "DEC-C2B8: Results of a Phase I Multiple-Dose Trial in Patients with Relapsed Non-Hodgkin's Lymphoma," J. Clinical Oncology, 15(10):3266-3274 (1997) Download
Nov 2, 2017 1019 Ex. 1019 - Roark et al., "Breakdown of B Cell Tolerance in a Mouse Model of Systemic Lupus Erythematosus," J. Experimental Medicine, 181:1157-1167 (1995) Download
Nov 2, 2017 1027 Ex. 1027 - U.S. Application No. 12/886,171, Non-Final Office Action (dated Mar. 20, 2012) Download
Nov 2, 2017 1011 Ex. 1011 - David G. Maloney et al., "IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients with Relapsed Low-grade Non-Hodgkin's Lymphoma," Blood, 90(6):2188-2195 (1997) Download
Nov 2, 2017 1024 Ex. 1024 - Tanya Doan and Elena Massarotti, "Rituximab," Drugs of Today, 41(12):785-797 (2005) ("Massarotti II") Download
Nov 2, 2017 1035 Ex. 1035 Physicians' Desk Reference (53rd ed. 1999) (excerpted), "Rituxan (Rituximab)" ("PDR label") Download
Nov 2, 2017 1006 Ex. 1006 - Rituxan (rituximab) labeling (Nov. 1997) ("FDA label") Download
Nov 2, 2017 1028 Ex. 1028 - U.S. Application No. 12/886,171, Amendment in Response to Final Action (dated Oct. 29, 2012) Download
Nov 2, 2017 1020 Ex. 1020 - Takeuchi et al., "Upregulated Expression and Function of Integrin Adhesive Receptors in Systemic Lupus Erythematosus Patients with Vasculitis,¿¿¿"J. Clinical Invest., 92:3008-3016 (1993) Download
Nov 2, 2017 1012 Ex. 1012 - Rituxan Full Prescribing Information, Genentech Wayback Machine Website. Download
Nov 2, 2017 1013 Ex. 1013 - Specks et al., "Response of Wegener¿¿¿s Granulomatosis to Anti-CD20 Chimeric Monoclonal Antibody Therapy," Arthritis & Rheumatism, 44(12): 2836-2840 (2001) Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 3 Download
Nov 2, 2017 1016 Ex. 1016 - Drenkard et al., "Vasculitis in Systemic Lupus Erythematosus," Lupus, 6:235-242 (1997) Download
Nov 2, 2017 1026 Ex. 1026 - U.S. Application No. 12/886,171, Amendment in Response to Non-Final Action (dated Apr. 11, 2011) Download
Nov 2, 2017 1009 Ex. 1009 - Niels Rasmussen and Jorgen Petersen, "Cellular Immune Responses and Pathogenesis in c-ANCA Positive Vasculitides,' J. Autoimmunity, 6(2): 227-236 (1993) Download
Nov 2, 2017 1036 Ex. 1036 - Maini et al., "Therapeutic Efficacy of Multiple Intravenous Infusions of Anti-Tumor Necrosis Factor Monoclonal Antibody Combined with Low-Dose Weekly Methotrexate in Rheumatoid Arthritis," Arthritis & Rheumatism, 41(9):1552-1563 (1998) Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 5 Download
Nov 2, 2017 1002 Ex. 1002 - Declaration of Elena M. Massarotti, M.D. Download
Nov 2, 2017 1021 Ex. 1021 - Cupps et al., "Suppression of Human B Lymphocyte Function by Cyclophosphamide," J. Immunology, 128(6):2453-2457 (1982) Download
Nov 2, 2017 1034 Ex. 1034 - Fauci et al., "Effect of Cyclophosphamide upon the Immune Response in Wegener's Granulomatosis," N.E. J. Med., 285(27):1493-1496 (1971) Download
Nov 2, 2017 1007 Ex. 1007 - George et al., "Infections and Wegener¿¿¿s Granulomatosis-A Cause and Effect Relationship?" Quarterly J. Med., 90:367-373 (1997) Download
Nov 2, 2017 1003 Ex. 1003 - Owen Chan and Mark J. Shlomchik, "A New Role for B Cells in Systemic Autoimmunity: B Cells Promote Spontaneous T Cell Activation in MRL-lpr/lpr Mice," J. Immunology, 160:51-59 (1998) Download
Nov 2, 2017 1014 Ex. 1014 - Stone et al., "Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis," N.E. J. Med., 363(3):221-232 (2010) Download
Nov 2, 2017 1015 Ex. 1015 - Press Release, National Institute of Allergy and Infectious Diseases (NIAID), "After 40 Years, NIH-Supported Researchers Identify Possible New Treatment for Severe Vasculitis,"(July 14, 2010) Download
Nov 2, 2017 1008 Ex. 1008 - Mathieson et al., "T and B Cell Responses to Neutrophil Cytoplasmic Antigens in Systemic Vasculitis," Clinical Immunology & Immunopathology, 63(2): 135-141 (1992) Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 3 Download
Nov 2, 2017 1031 Ex. 1031 - E. William St. Clair "Chapter 10: Vasculitis," in Treatment of the Rheumatic Diseases: Companion to the Textbook of Rheumatology (Michael H. Weisman & Michael E. Weinblatt eds.) 137-157 (1995) Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 1 Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 2 Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 4 Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 3 Download
Nov 2, 2017 1010 Ex. 1010 - Excerpts from Vols. 1 & 2 Textbook of Rheumatology 5th Ed. (Kelley et al., eds) (1997) ("Kelley Textbook") - Part 6 Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 1 Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 5 Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 4 Download
Nov 2, 2017 1025 Ex. 1025 - Declaration of Scott Bennett, Ph.D. Part 2 Download
Menu